COMMUNIQUÉS West-GlobeNewswire

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
26/05/2026
Drs. Sang-Won Lee and Jaewoo Kang to share early insights from Seer's 20,000-sample collaboration with Korea University in breakfast symposium on AI-driven multi-cancer screening REDWOOD CITY, Calif., May 26, 2026 ( [...]
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
26/05/2026
New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence SALT LAKE CITY, May 26, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic [...]
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26/05/2026
SAN FRANCISCO, May 26, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
26/05/2026
SOUTH SAN FRANCISCO, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
26/05/2026
Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five late-stage global clinical trials in obesity, including the ribupatide injection KaiNETIC Phase 3 [...]
Lakefront Receives Transparency Notification from Bank of America
26/05/2026
Mechelen, Belgium; May 26, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Bank of America. Pursuant to Belgian transparency [...]
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026
26/05/2026
Webcast to be held Wednesday, May 27th at 8:00 a.m. ET SAN FRANCISCO and BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, [...]
Dianthus Therapeutics to Participate in Two Investor Conferences
26/05/2026
NEW YORK and WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Arcutis Management to Present at Goldman Sachs 47th Annual Global Healthcare Conference
26/05/2026
WESTLAKE VILLAGE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Inventiva Reports 2026 First Quarter Financial Information¹
26/05/2026
Cash and cash equivalents at €75.0 million, and €121.5 million in short-term deposits 2 Daix (France), New York City (New York, United States), May 26, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or [...]
Inventiva publie ses informations financières du premier trimestre 2026¹
26/05/2026
Trésorerie et équivalents de trésorerie de 75 millions d'euros, et 121,5millions d'euros de dépôts à court terme 2025 2 Daix (France), New York City (New York, United States), le 26 mai 2026 – Inventiva (Euronext Paris [...]
OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
26/05/2026
WARSAW, Ind., May 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced [...]
Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies
26/05/2026
ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved insulin sensitivity, enhanced adipose function, and improved liver [...]
Affordable GLP-1 Telehealth Platform Ozari Health Announces New Industry-Wide Research Analysis on GLP-1 Pricing Data
26/05/2026
Ozari Health publishes first-of-its-kind pricing analysis to help patients understand the real cost of GLP-1 medications. New York, NY, May 26, 2026 (GLOBE NEWSWIRE) -- Ozari Health , the New York-based telehealth [...]
IBA – ACQUISITION OF OWN SHARES
26/05/2026
Louvain-la-Neuve, Belgium, May 26 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
IBA – ACQUISITION D’ACTIONS PROPRES
26/05/2026
Louvain-la-Neuve, Belgique, 26 mai 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
Comprehensive Healthcare launches Comprehensive Mobile Unit in Ellensburg
26/05/2026
New mobile unit expands opioid treatment access to Kittitas County YAKIMA, Wash., May 26, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is bringing life-saving opioid treatment to Kittitas County with the launch of [...]
SBC Medical will participate in several upcoming investor conferences in May and June 2026
26/05/2026
IRVINE, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
26/05/2026
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL [...]

Pages